Trial Oversight Spotlight #1: Smaranda Doucet
In this episode:
Tom sits down with Smaranda Doucet, Founder, FlowTrial. Tom and Smaranda explore the follow key topics of trial oversight through their own lenses:
Key points:
- Actionable tactics to deliver effective oversight
- What are Oversight Services?
- How does ICH GCP Revision 3 impact Sponsor Oversight?
Time stamps:
- – Smaranda Intro
- – Sponsor Capabilities Assessment
- – What are Clinical Trial Oversight Services?
- – Sponsor Oversight Misconceptions
- – Practical Approaches to Sponsor Oversight
- – The next level of Sponsor Oversight
- – A success story from Smaranda
- – Impact of GCP Revision 3 on Sponsor Oversight
- – Top Tips for Sponsor Oversight
Guest Bio
Smaranda Doucet
Founder & CEO, Flow Trial
Smaranda Doucet is the CEO of Flow Trial, with over 15 years of experience in the clinical trials industry. She has held various roles, from founder and manager of a CRO to consulting for various pharmaceutical start-ups.
Smaranda is dedicated to supporting sponsors in achieving their oversight responsibilities through tailored solutions and hands-on expertise.
Host Bio
Tom is running the Trial Oversight Spotlight Interview Series where he meets with a variety of colleagues working in clinical research. They discuss a selection of the most important topics and decisions that are currently being navigated by all types of organisations delivering research.